Skip to main content

Table 1 Main clinical characteristics and parameters in 447 patients with ESCC

From: Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma

Characteristics

Median (25th–75th percentile) or no. (%)

Gender (n)

 Male

346 (77.4)

 Female

101 (22.6)

Age

  < 59 years

233 (52.1)

  ≥ 59 years

214 (47.9)

Alcohol (n)

 No

261 (58.4)

 Yes

186 (41.6)

Tumor location

 Upper

41 (9.2)

 Middle

278 (62.2)

 Lower

128 (28.6)

Stage (n)

 I and II

235 (52.6)

 III and IV

212 (47.4)

Treatment (n)

 Surgery only

238 (53.2)

 Surgery and chemotherapy

179 (40.0)

 Surgery and radiotherapy

6 (1.3)

 Surgery and chemotherapy and radiotherapy

24 (5.4)

Deads (n)

 No

199 (44.5)

 Yes

248 (55.5)

Tests

 GGT

23.1 (16.8–35.2)

 LDH

154.4 (135.7–174.2)

 TBA

4.14 (2.43–6.65)

 ALT

15.1 (11.5–20.8)

 AST

18.2 (15.8–22.1)

 ALT/AST

0.82 (0.67–1.02)